Premier Fund Managers Ltd lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 9,864 shares of the biopharmaceutical company’s stock after selling 800 shares during the quarter. Premier Fund Managers Ltd’s holdings in Gilead Sciences […]